Our results showed that DNMT1 expression was elevated from non-neoplastic to tumor tissue at the mRNA and protein levels and further increased with grade progression and in tumor relapses, and its phosphorylation levels were also increased in carcinomas. Here, DNMT1 is linked to carcinoma.